BRIANNE LIENKAMP: Open Payments
NPI 1639422355 · MARION, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,928 in 78 payments from 10 companies in 2025. Trend: 2023 $25,430 · 2024 $65,472 · 2025 $26,928
Speaker / faculty: $18,520Travel & lodging: $6,919Food & beverage: $1,490
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 41 | $26,169 |
| Axsome Therapeutics, Inc. | 9 | $243 |
| E.R. Squibb & Sons, L.L.C. | 7 | $224 |
| ABBVIE INC. | 13 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Braeburn Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $25 |
| Alkermes, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: SPRAVATO, COBENFY, Sunosi, VRAYLAR, Auvelity, CAPLYTA, BRIXADI, Qelbree.
Industry payments across MA — which companies pay providers there.
